Shopping Cart 0
Cart Subtotal
USD 0

Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4199

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6299

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8399
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers forecast and analysis for the antifungal drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the antifungal drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the antifungal drug market on a global level. This report offers comprehensive coverage on global antifungal drug market along with, market trends, drivers, and restraints of the antifungal drug market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the antifungal drug market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts. The study provides a decisive view on the antifungal drug market by segmenting the market based on drug type, therapeutic indication, dosage form, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The drug type market covered under this study includes echinocandins, azoles, ployenes, allylamines and others. The therapeutic indication segmentation includes aspergillosis, dermatophytosis, candidiasis and others. The dosage form segmentation includes powder, ointment, drug, and paste. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into US, UK, Germany, France, Japan, China, India, and Brazil. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, Glaxosmithkline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead. This report segments the global antifungal drug market as follows: Global Antifungal Drug Market: Drug Type Analysis Echinocandins Azoles Polyenes Allylamines Others Global Antifungal Drug Market: Therapeutic Indication Analysis Aspergillosis Dermatophytosis Candidiasis Others Global Antifungal Drug Market: Dosage Form Analysis Powders Ointments Drugs Pastes Global Antifungal Drug Market: Regional Segment Analysis North America US Europe UK Germany France Asia Pacific China Japan India Latin America Brazil Middle East And Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Antifungal Drug Market, 2015-2021 (USD Billion) 2.2. Global Antifungal Drug Market: Snapshot Chapter 3. Antifungal Drug Market Dynamics 3.1. Introduction 3.2. Value Chain Analysis 3.3. Market Drivers 3.3.1. Global Antifungal Drug Market Drivers: Impact Analysis 3.3.2. Rapid Spread Of Fungal Infection 3.3.3. Pandemicity Of Fungal Infection 3.4. Market Restraints 3.4.1. Global Antifungal Drug Market Restraints: Impact Analysis 3.4.2. High Penetration Of Conventional Drugs 3.5. Opportunities 3.5.1. Covering Untapped Market 3.6. Porters Five Forces Analysis 3.6.1. Bargaining Power Of Suppliers 3.6.2. Bargaining Power Of Buyers 3.6.3. Threat From New Entrants 3.6.4. Threat From New Substitutes 3.6.5. Degree Of Competition 3.7. Market Attractiveness Analysis 3.7.1. Market Attractiveness Analysis, By Drug Type Segment 3.7.2. Market Attractiveness Analysis, By Therapeutic Indication Segment 3.7.3. Market Attractiveness Analysis, By Dosage Form Segment 3.7.4. Market Attractiveness Analysis, By Regional Segment Chapter 4. Global Antifungal Drug Market Competitive Landscape 4.1. Company Market Share, 2015 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Type Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Regional Expansion 4.3. Type Portfolio Chapter 5. Global Antifungal Drug Market Test Analysis 5.1. Global Antifungal Drug Market: Test Overview 5.1.1. Global Antifungal Drug Market Revenue Share, By Test , 2015 And 2021 5.2. Echinocandins 5.2.1. Global Echinocandins Testing Market, 2015 2021 (USD Billion) 5.3. Azoles 5.3.1. Global Azoles Market, 2015 2021 (USD Billion) 5.4. Ployenes 5.4.1. Global Ployenes Market, 2015 2021 (USD Billion) 5.5. Allylamines 5.5.1. Global Allylamines Market, 2015 2021 (USD Billion) 5.6. Others 5.6.1. Global Other Antifungal Drug Market, 2015 2021 (USD Billion) Chapter 6. Global Antifungal Drug Market Therapeutic Indication Analysis 6.1. Global Antifungal Drug Market: Therapeutic Indication Segment Overview 6.1.1. Global Antifungal Drug Market Revenue Share, By Therapeutic Indication, 2015 And 2021 6.2. Aspergillosis 6.2.1. Global Antifungal Drug Market For Aspergillosis, 2015 2021 (USD Billion) 6.3. Dermatophytosis 6.3.1. Global Antifungal Drug Market For Dermatophytosis, 2015 2021 (USD Billion) 6.4. Candidiasis 6.4.1. Global Antifungal Drug Market For Candidiasis, 2015 2021 (USD Billion) 6.5. Others 6.5.1. Global Antifungal Drug For Others Therapeutic Indication Market, 2015 2021 (USD Billion) Chapter 7. Global Antifungal Drug Market Dosage Form Analysis 7.1. Global Antifungal Drug Market: Dosage Form Segment Overview 7.1.1. Global Antifungal Drug Market Revenue Share, By Dosage Form, 2015 And 2021 7.2. Powders 7.2.1. Global Antifungal Drug Market For Powders, 2015 2021 (USD Billion) 7.3. Ointment 7.3.1. Global Antifungal Drug For Ointment Market, 2015 2021 (USD Billion) 7.4. Drugs 7.4.1. Global Antifungal Drug Market For Drugs, 2015 2021 (USD Billion) 7.5. Paste 7.5.1. Global Antifungal Drug For Paste Market, 2015 2021 (USD Billion) Chapter 8. Global Antifungal Drug Market Regional Segment Analysis 8.1. Global Antifungal Drug Market: Regional Overview 8.1.1. Global Antifungal Drug Market Revenue Share, By Region, 2015 And 2021 8.2. North America 8.2.1. North America Antifungal Drug Market Revenue, By Drug Type , 2015 2021 , (USD Billion) 8.2.2. North America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 , (USD Billion) 8.2.3. North America Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 , (USD Billion) 8.2.4. U.S. 8.2.4.1. U.S. Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.2.5. U.S. 8.2.5.1. U.S. Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.2.6. U.S. 8.2.6.1. U.S. Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.3. Europe 8.3.1. Europe Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.3.2. Europe Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.3.3. Europe Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.3.4. Germany 8.3.4.1. Germany Antifungal Drug Market Revenue, By Drug Type , 2015 2021, (USD Billion) 8.3.4.2. Germany Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021, (USD Billion) 8.3.4.3. Germany Antifungal Drug Market Revenue, By Dosage Form , 2015 2021, (USD Billion) 8.3.5. France 8.3.5.1. France Antifungal Drug Market Revenue, By Drug Type , 2015 2021, (USD Billion) 8.3.5.2. France Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021, (USD Billion) 8.3.5.3. France Antifungal Drug Market Revenue, By Dosage Form , 2015 2021, (USD Billion) 8.3.6. UK 8.3.6.1. UK Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.3.6.2. UK Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.3.6.3. UK Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.4. Asia Pacific 8.4.1. Asia Pacific Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.4.2. Asia Pacific Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.4.3. Asia Pacific Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.4.4. China 8.4.4.1. China Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.4.4.2. China Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.4.4.3. China Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.4.5. Japan 8.4.5.1. Japan Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.4.5.2. Japan Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.4.5.3. Japan Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.4.6. India 8.4.6.1. India Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.4.6.2. India Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.4.6.3. India Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.5. Latin America 8.5.1. Latin America Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.5.2. Latin America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.5.3. Latin America Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.5.4. Brazil 8.5.4.1. Brazil Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.5.4.2. Brazil Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.5.4.3. Brazil Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) 8.6. Middle East And Africa 8.6.1. Middle East And Africa Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion) 8.6.2. Middle East And Africa Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion) 8.6.3. Middle East And Africa Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion) Chapter 9. Company Profile 9.1. Asperqillus 9.1.1. Overview 9.1.2. Financials 9.1.3. Product Portfolio 9.1.4. Business Strategy 9.1.5. Recent Developments 9.2. Alternaria 9.2.1. Overview 9.2.2. Financials 9.2.3. Product Portfolio 9.2.4. Business Strategy 9.2.5. Recent Developments 9.3. Abbott Laboratories 9.3.1. Overview 9.3.2. Financials 9.3.3. Product Portfolio 9.3.4. Business Strategy 9.3.5. Recent Developments 9.4. Pfizer 9.4.1. Overview 9.4.2. Financials 9.4.3. Product Portfolio 9.4.4. Business Strategy 9.4.5. Recent Developments 9.5. Glaxosmithkline 9.5.1. Overview 9.5.2. Financials 9.5.3. Product Portfolio 9.5.4. Business Strategy 9.5.5. Recent Developments 9.6. Bayer Healthcare 9.6.1. Overview 9.6.2. Financials 9.6.3. Product Portfolio 9.6.4. Business Strategy 9.6.5. Recent Developments 9.7. Novartis 9.7.1. Overview 9.7.2. Financials 9.7.3. Product Portfolio 9.7.4. Business Strategy 9.7.5. Recent Developments 9.8. Sanofi-Aventis 9.8.1. Overview 9.8.2. Financials 9.8.3. Product Portfolio 9.8.4. Business Strategy 9.8.5. Recent Developments 9.9. Merck Co. 9.9.1. Overview 9.9.2. Financials 9.9.3. Product Portfolio 9.9.4. Business Strategy 9.9.5. Recent Developments 9.10. Kramer Laboratories 9.10.1. Overview 9.10.2. Financials 9.10.3. Product Portfolio 9.10.4. Business Strategy 9.10.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com